Mary K. Marks
Lawyers
Filters
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
Bridgepoint sale of DMC Power to Golden Gate Capital
We advised Bridgepoint on the transaction
Lucid Group $232 million strategic supply agreement with Aston Martin
We are advising Lucid Group on the transaction
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
GSK exclusive licensing agreement with Scynexis
We advised GSK on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Carrier Global €12 billion acquisition of Viessmann Climate Solutions
We are advising Viessmann Group on the transaction
Japan Industrial Partners $15.2 billion acquisition of Toshiba
We are advising Japan Industrial Partners on the acquisition
Pon sale of interest in Hiller to Littlejohn & Co.
We advised Pon on the transaction